Condition: Multidrug Resistant Tuberculosis · Rifampicin Resistant Tuberculosis · Pre-XDR-TB · Sponsor: Huashan Hospital
The INSPIRE-TB study is a pragmatic, multicentre, randomised, controlled, non-inferiority open-label trial to evaluate the efficacy and safety of seven 9-month oral regimens compared to a 9-month standard of care (SOC) regimen in RR-TB participants susceptible to fluoroquinolones, and a bedaquiline-containing 9-month oral regimen compared to a 20-month conventional regimen in RR-TB participants resistant to fluoroquinolones
This description comes directly from the study's public registry record.
Feng Sun, Dr. · (086)15921403893 · feng.sun@nmcid.org.cn
Yang Li, Dr. · (086)18817583793 · lalaliy@sina.com
Always discuss trial participation with your own doctor first.
| Guiyang Public Health Treatment Center | Guiyang, Guizhou, China | Recruiting |
| People's Hospital of Qiandongnan | Kaili, Guizhou, China | Recruiting |
| The Third People's Hospital of Liupanshui | Liupanshui, Guizhou, China | Recruiting |
| Affiliated Hospital of Zunyi Medical University | Zunyi, Guizhou, China | Recruiting |
| Huashan Hospital of Fudan University | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05081401